Company / R&D Expense
Lantheus Holdings R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$177.3M
FY2025
5-year range
$45.0M / $311.7M
FY2021-FY2025
Trend
+5.5%
vs FY2024
Sector context
#42 of 110
Health Care
What the data says
At $177M, Lantheus Holdings's r&d expense ranks #42 of 110 in the Health Care sector. R&D Expense has fluctuated over the past 10 years, ranging from $12M in FY2018 to $312M in FY2022.
Based on SEC 10-K filings.
$177M in FY2025 with a 5-year CAGR of +40.2%.
Improved from $78M to $177M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -17.1%
- 5-Year CAGR
- +40.2%
- 10-Year CAGR
- -
Sector benchmark
#42 of 110 in Health CareTop 38% of 110This company $177.3M Sector average $298.2M
▼
-40.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.2%, indicating consistent growth.
- In FY2025, r&d expense increased 5.5% year-over-year.
- Ranks #42 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $177.3M | +5.5% |
| FY2024 | $168.1M | +116.3% |
| FY2023 | $77.7M | -75.1% |
| FY2022 | $311.7M | +593.1% |
| FY2021 | $45.0M | +37.1% |
| FY2020 | $32.8M | +63.8% |
| FY2019 | $20.0M | +64.0% |
| FY2018 | $12.2M | -15.0% |
| FY2017 | $14.4M | +5.0% |
| FY2016 | $13.7M | -55.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026